## Abstract ## BACKGROUND The objective of this study was to determine the clinical characteristics, treatment response, and frequency of __p53__ overexpression in Ashkenazi Jewish women with hereditary ovarian carcinoma. ## METHODS Seventy‐one Jewish women with epithelial ovarian carcinoma (EOC
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
✍ Scribed by Lilach Kleinberg; Vivi Ann Flørenes; Ilvars Silins; Kristiane Haug; Claes G. Trope; Jahn M. Nesland; Ben Davidson
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 631 KB
- Volume
- 109
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Death receptors mediate both apoptosis and survival in cancer cells. The authors analyzed death receptor expression in metastatic ovarian carcinoma. ## METHODS. Viable tumor cells in ovarian carcinoma effusions (n = 95) were analyzed for DR4, DR5, Fas, TNFR1, and TNFR2
## Abstract ## BACKGROUND Survivin counteracts cell death and controls mitotic progression. The objectives of the current study were to compare the expression patterns of survivin in normal prostate, primary prostate carcinoma, and lymph node tissues involved with prostate carcinoma and to determi
Expression of mdm-2 mRNA was measured in 90 ovarian-cancer tissue specimens using the S1 nuclease assay, to investigate a possible association between MDM2 expression and prognosis. mdm-2 mRNA expression was an independent prognostic factor for patients with primary ovarian cancer, FIGO (Internation
## Abstract ## BACKGROUND The nucleotide excision repair (NER) proteins repair DNA adducts due to xenobiotics and cancer chemotherapy. The authors hypothesized that expression of the NER protein xeroderma pigmentosum A (XPA) would be reduced in a clinically significant fashion in metastatic ovaria